| Leona Council, MD | |
|
619 19th St S, Birmingham, AL 35249-1900 | |
| (205) 934-5038 | |
| Not Available |
| Full Name | Leona Council |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 20 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013127315 | NPI | - | NPPES |
| 101636 | Medicaid | AL | |
| 051548749 | Other | AL | BCBS |
| 051548750 | Other | AL | BCBS |
| 051548751 | Other | AL | BCBS |
| 101637 | Medicaid | AL | |
| 101638 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 27055 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
New guidelines from the American Cancer Society (ACS) recommend that women at very high risk for breast cancer receive magnetic resonance imaging (MRI) along with annual mammography, reports the October 2007 issue of Harvard Women's Health Watch .
BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company's potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI's plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.
Enrollment in both new and existing U.S. medical schools continues to expand to meet the nation's need for more doctors, according to data released today by the AAMC (Association of American Medical Colleges).
This briefing, for reporters only, will look at some of the important issues that must be settled if President Obama is to sign a meaningful health reform bill this year.
› Verified 1 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
New guidelines from the American Cancer Society (ACS) recommend that women at very high risk for breast cancer receive magnetic resonance imaging (MRI) along with annual mammography, reports the October 2007 issue of Harvard Women's Health Watch .
BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company's potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI's plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.
Enrollment in both new and existing U.S. medical schools continues to expand to meet the nation's need for more doctors, according to data released today by the AAMC (Association of American Medical Colleges).
This briefing, for reporters only, will look at some of the important issues that must be settled if President Obama is to sign a meaningful health reform bill this year.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leona Council, MD Po Box 55310, Birmingham, AL 35233-5310 Ph: () - | Leona Council, MD 619 19th St S, Birmingham, AL 35249-1900 Ph: (205) 934-5038 |
News Archive
New guidelines from the American Cancer Society (ACS) recommend that women at very high risk for breast cancer receive magnetic resonance imaging (MRI) along with annual mammography, reports the October 2007 issue of Harvard Women's Health Watch .
BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company's potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI's plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.
Enrollment in both new and existing U.S. medical schools continues to expand to meet the nation's need for more doctors, according to data released today by the AAMC (Association of American Medical Colleges).
This briefing, for reporters only, will look at some of the important issues that must be settled if President Obama is to sign a meaningful health reform bill this year.
› Verified 1 days ago
Dr. Kyle Charles Mills, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2800 Fax: 205-949-2801 | |
Dr. Alexander Wong, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2806 Fax: 205-949-2875 | |
Dr. David Ullman, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-934-4977 | |
Dr. Jonathan G Phillips, MD Pathology Medicare: Medicare Enrolled Practice Location: 924 Montclair Rd, Ste 200, Birmingham, AL 35213 Phone: 205-591-7999 Fax: 205-591-5051 | |
Thomas S Winokur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Isam Eltoum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |